Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Lentinus edodes (shiitake) is a widely consumed edible and medicinal mushroom known for its bioactive polysaccharides and potential therapeutic applications [PMID:20491636, PMID:32450024].
Contexte
Lentinus edodes, also known as Lentinula edodes, is a basidiomycete macrofungus cultivated in East Asia for thousands of years and is currently the second most commonly produced edible mushroom globally [PMID:1395630, PMID:32450024].
Usages traditionnels
It has been used medicinally for conditions including cancer, AIDS (depressed immune function), environmental allergies, fungal infections, frequent flu and colds, bronchial inflammation, heart disease, hyperlipidemia, hypertension, infectious disease, diabetes, hepatitis, and urinary inconsistencies [PMID:20491636].
Composés actifs
Key bioactive compounds include polysaccharides (specifically beta-glucans such as lentinan), eritadenine, ergosterol, erythritol, copalic acid, adenosine, and carvacrol [PMID:20491636, PMID:28082791, PMID:32450024, PMID:42068818].
Mécanisme d'action
L. edodes polysaccharides exhibit immunomodulatory, antioxidant, and anti-inflammatory properties [PMID:36012249, PMID:33940295]. Ergosterol from shiitake-derived vesicle-like nanoparticles suppresses the NLRP3 inflammasome by mitigating mitochondrial damage and acting through Bmal1 [PMID:42068818]. Mycelia polysaccharides (LMP) may inhibit obesity by binding to lipase via hydrogen bonding and van der Waals forces [PMID:34918387].
Preuves cliniques
Preuve DCognitive Decline (Aged Mice)
Orally administered shiitake mushroom-derived vesicle-like nanoparticles (S-VLNs) improved cognitive function and reshaped gut microbiota and fecal metabolome [PMID:40944290]
Preuve DOxidative Stress (Dogs)
Supplementation with shiitake powder (800 mg/kg bw/day) increased antioxidative activity, decreased plasma total cholesterol, and increased superoxide dismutase activity [PMID:38962708]
Preuve DBlood Parameters (Racehorses)
Daily supplementation of 30g L. edodes for four months resulted in lower alkaline phosphatase levels and decreased glucose levels on specific days [PMID:36428438]
Preuve DLPS-induced hematological changes (Mice)
Beta-glucan extract (BG) and lentinan (LNT) attenuated acute effects of lipopolysaccharides on peripheral hematological parameters [PMID:37396940]
Sécurité et effets indésirables
Consumption of raw or undercooked shiitake mushrooms can cause 'shiitake mushroom dermatitis,' a cutaneous reaction characterized by linear erythematous eruptions (flagellate dermatitis) with papules, papulovesicles, or plaques and severe pruritus [PMID:27566177, PMID:29469797, PMID:42227903]. This is likely caused by lentinan, a heat-inactivated beta-glucan polysaccharide [PMID:27566177]. Allergic contact dermatitis may also occur from handling the mushroom [PMID:27566177].
Synthèse des preuves
The evidence consists primarily of reviews, case reports of adverse dermatological reactions, and animal-model studies (mice, dogs, horses). There is a lack of high-level human clinical trials (RCTs) in the provided data.
Sources PubMed
1.PMID: 27566177 (2016) — Shiitake Mushroom Dermatitis: A Review. · American journal of clinical dermatology
5.PMID: 28082791 (2016) — The Unexplored Anticaries Potential of Shiitake Mushroom. · Pharmacognosy reviews
6.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
PMID: 31543768 (2019) — Flagellate Dermatitis by Shiitake Mushroom. · Case reports in dermatology
7.PMID: 36012249 (2022) — Immunomodulatory Properties of Polysaccharides from Lentinula edodes. · International journal of molecular sciences
8.PMID: 42227903 (2026) — [A woman with 'whip marks']. · Nederlands tijdschrift voor geneeskunde
9.PMID: 33940295 (2021) — Recent advances in polysaccharides from Lentinus edodes (Berk.): Isolation, structures and bioactivities. · Food chemistry
10.PMID: 40944290 (2025) — Shiitake Mushroom-Derived Vesicle-like Nanoparticles Improve Cognitive Function and Reshape Gut Microbiota and Fecal Metabolome in Aged Mice. · Nutrients
11.PMID: 20491636 (2010) — Lentinus edodes: a macrofungus with pharmacological activities. · Current medicinal chemistry
12.PMID: 39194878 (2024) — Chemical Composition, Antioxidant and Anti-Inflammatory Activity of Shiitake Mushrooms (Lentinus edodes). · Journal of fungi (Basel, Switzerland)
13.PMID: 32450024 (2019) — Review of Bioactive Molecules Production, Biomass, and Basidiomata of Shiitake Culinary-Medicinal Mushrooms, Lentinus edodes (Agaricomycetes). · International journal of medicinal mushrooms
14.PMID: 38962708 (2024) — Shiitake mushroom powder supplementation increase antioxidative activity in dogs. · Frontiers in veterinary science
15.PMID: 36921827 (2023) — Characterization of an active film prepared with Lentinus edodes (shiitake) polysaccharide and its effect on post-harvest quality and storage of shiitake. · International journal of biological macromolecules
16.PMID: 34918387 (2022) — Binding mechanism of lipase with Lentinus edodes mycelia polysaccharide by multi-spectroscopic methods. · Journal of molecular recognition : JMR
17.PMID: 25975107 (2014) — [Antiviral properties of basidiomycetes metabolites]. · Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]
18.PMID: 37444272 (2023) — Preparation and Identification of Peptides with α-Glucosidase Inhibitory Activity from Shiitake Mushroom (Lentinus edodes) Protein. · Foods (Basel, Switzerland)
19.PMID: 37396940 (2023) — Lentinan and β-glucan extract from shiitake mushroom, Lentinula edodes, alleviate acute LPS-induced hematological changes in mice. · Iranian journal of basic medical sciences
20.PMID: 36428438 (2022) — Evaluation of Shiitake Mushroom (Lentinula edodes) Supplementation on the Blood Parameters of Young Thoroughbred Racehorses. · Animals : an open access journal from MDPI